ArticleMedical oncology (Northwood, London, England)2026
A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K/AKT pathway to inhibit prostate cancer progression.
Xianhui Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.